infect
rna
virus
gener
extens
divers
due
high
mutat
rate
mutat
per
nucleotid
copi
larg
attribut
error
rate
viral
rnadepend
rna
polymeras
rdrp
past
decad
engin
rna
virus
variou
famili
alter
mutat
rate
shown
singl
substitut
significantli
alter
polymeras
activ
fidel
among
variant
rdrp
mutat
present
point
mutat
viral
polymeras
lead
increas
mutat
rate
compar
wildtyp
wt
viru
mutat
variant
introduc
vivo
variou
anim
model
major
significantli
attenu
exampl
rdrp
mutat
variant
chikungunya
viru
chikv
sindbi
viru
sinv
attenu
fruit
fli
mice
attenu
observ
vivo
directli
correl
increas
mutat
rate
would
presum
result
higher
frequenc
lethal
mutat
inde
mutat
strain
rna
virus
present
mutat
frequenc
profil
similar
wildtypelik
virus
whose
mutat
rate
extrins
increas
treatment
rna
mutagen
studi
evalu
lethal
mutagenesi
antivir
strategi
howev
mani
determin
alter
rdrp
fidel
identifi
enzymat
mechan
dynam
occur
well
elucid
decreas
fidel
may
affect
polymeras
activ
unclear
anoth
curiou
featur
rna
viru
replic
product
truncat
genom
defect
interf
particl
di
first
report
von
magnu
later
explor
huang
holland
di
product
describ
almost
everi
rna
viru
famili
di
truncat
form
viral
genom
accumul
replic
especi
passag
cell
cultur
high
multipl
infect
moi
di
lack
one
sever
part
codingnoncod
sequenc
highjack
fulllength
viru
protein
replic
packag
transmiss
interfer
replic
fulllength
viru
addit
interfer
di
implic
preferenti
activ
type
interferon
vivo
via
detect
cytoplasm
sensor
rigi
also
enhanc
dendrit
cell
matur
abil
recombin
homolog
nonhomolog
manner
import
driver
viral
evolut
wellknown
featur
rna
virus
process
reli
copi
choic
mechan
viral
rdrp
switch
templat
rna
synthesi
pursu
elong
nascent
rna
di
format
correspond
context
switch
two
noncolinear
fragment
viral
genom
could
equal
happen
two
separ
viral
rna
intermolecular
one
viral
genom
intramolecular
second
mechan
di
format
reli
nonrepl
recombin
fragment
viral
genom
relig
togeth
independ
rdrp
activ
howev
event
thought
rare
enough
vast
major
di
aris
copi
choic
recombin
work
character
behavior
rdrp
mutat
sindbi
viru
sinv
togavirida
famili
first
assess
abil
sinv
mutat
term
sinvg
sinv
mutat
produc
di
particl
passag
high
multipl
infect
moi
monitor
accumul
di
throughout
passag
show
sinvg
accumul
di
higher
rate
di
produc
sinvg
implic
interfer
fulllength
viru
replic
strikingli
observ
import
increas
recombin
rate
mutat
find
demonstr
along
increas
error
rate
higher
recombin
rate
gener
characterist
rdrp
mutat
furthermor
higher
recombin
rate
lead
increas
di
product
may
previous
overlook
main
contributor
mutat
vivo
attenu
mammalian
cell
line
vero
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
supplement
newborn
calf
serum
nc
gibco
penicillinstreptomycin
ps
sigma
sindbi
virus
gener
infecti
clone
linear
xhoi
linear
product
purifi
phenolchloroform
extract
subsequ
use
vitro
transcript
viral
rna
use
mmessag
mmachin
kit
ambion
rna
purifi
phenolchloroform
extract
quantifi
dilut
store
gener
viru
stock
cell
transfect
viral
rna
follow
cell
trypsin
wash
twice
icecold
phosphatebuff
salin
pb
resuspend
concentr
cellsml
icecold
pb
cell
ml
mix
vitrotranscrib
ivt
viral
rna
place
cuvett
electropor
kv
infinit
xcell
gene
pulser
biorad
follow
electropor
cell
plate
flask
h
supernat
collect
titrat
plaqu
assay
viru
passag
confluent
monolay
cell
order
gener
viru
stock
viru
supernat
aliquot
h
postinfect
store
mutat
stock
resequenc
rdrp
mutat
posit
check
revers
twelvewel
plate
seed
vero
cell
per
well
day
follow
day
serial
dilut
viru
dmem
incub
cell
monolay
h
follow
incub
cell
overlaid
dmem
contain
nc
agaros
plate
incub
h
cell
fix
formalin
h
plaqu
visual
addit
crystal
violet
cell
infect
h
moi
indic
text
figur
legend
viru
remov
extens
pb
wash
supernat
collect
variou
time
point
postinfect
passag
carri
total
ml
supernat
moi
indic
text
figur
legend
viral
titer
low
allow
moi
fix
amount
ml
supernat
use
infect
next
passag
rna
infect
cell
viru
suspens
extract
use
trizol
reagent
invitrogen
rna
sampl
prepar
use
northernmax
formaldehyd
load
dye
ambion
ethidium
bromid
heat
min
sampl
separ
lowelectroendosmosi
le
agaros
lonza
gel
contain
morpholinepropanesulfon
acid
mop
run
buffer
ambion
formaldehyd
rna
transfer
onto
nitrocellulos
membran
overnight
crosslink
uv
irradi
uvp
membran
block
h
ultrahyb
ultrasensit
hybrid
buffer
ambion
rna
probe
complementari
positivestrand
rna
synthes
use
maxiscript
vitro
transcript
kit
ambion
label
remov
unincorpor
nucleotid
use
illustra
microspin
hr
column
probe
hybrid
membran
overnight
membran
wash
three
time
wash
buffer
sd
autoclav
water
ssc
nacl
plu
sodium
citrat
min
imag
use
amersham
hyperfilm
mp
autoradiographi
film
ge
healthcar
viral
supernat
centrifug
g
min
remov
dead
cell
treat
rnase
thermo
scientif
room
temperatur
h
three
millilit
sucros
dilut
pb
pour
opentop
centrifug
tube
beckman
coulter
overlaid
ml
viral
supernat
tube
centrifug
g
h
use
ti
rotor
optima
ultracentrifug
beckman
coulter
supernat
remov
purifi
viru
pellet
resuspend
ml
pb
store
rna
sampl
retrotranscrib
cdna
use
maxima
h
minu
first
strand
cdna
synthesi
kit
thermo
scientif
oligo
dt
accord
manufactur
instruct
detect
dg
defect
genom
sinvg
pcr
perform
use
phusion
polymeras
thermo
scientif
primer
pair
obtain
sequenc
dg
band
gel
extract
use
qiaquick
gel
extract
kit
qiagen
submit
second
pcr
primer
sequenc
obtain
gatc
biotech
quantit
pcr
qpcr
cdna
mix
power
sybr
green
pcr
master
mix
appli
biosystem
follow
primer
pair
fulllength
genom
dg
dwt
defect
genom
sinvwt
stepon
plu
realtim
pcr
system
machin
appli
biosystem
use
accord
manufactur
instruct
cell
transfect
mix
rna
total
use
jetprim
reagent
accord
manufactur
instruct
establish
stabl
cell
line
plasmid
life
technolog
engin
express
construct
interest
linear
transfect
cell
stabl
cell
line
isol
endpoint
dilut
accord
manufactur
instruct
unless
indic
otherwis
experi
perform
technic
triplic
repeat
three
time
biolog
triplic
test
perform
use
microsoft
excel
graphpad
prism
p
valu
consid
nonsignific
sinv
mutat
sinvg
wildtypelik
growth
kinet
onestep
growth
curv
low
fig
high
fig
multipl
infect
moi
assess
activ
extend
passag
thu
passag
sinv
wildtyp
sinvwt
sinvg
low
moi
high
moi
moi
passag
assess
viral
titer
sequenc
confirm
mutat
stabl
throughout
passag
sinvwt
sinvg
present
similar
titer
kinet
lowmoi
passag
fig
sinvg
significantli
drop
titer
two
passag
earlier
sinvwt
high
moi
fig
inde
di
accumul
trigger
drop
viral
titer
via
defect
interfer
highmoi
passag
cell
cultur
data
suggest
sinvg
mutat
may
produc
di
particl
rapidli
greater
number
wildtyp
viru
di
might
viral
genom
bear
deleteri
mutat
could
accumul
greater
extent
mutat
viru
passag
altern
di
could
intern
delet
genom
address
hypothesi
isol
put
di
reason
di
abil
interfer
reli
capac
replic
encapsid
transmit
passag
consequ
di
conserv
replic
signal
carri
end
genom
well
encapsid
signal
code
sequenc
set
rtpcr
pcr
primer
locat
end
genom
anneal
fulllength
genom
di
perform
vitrotranscrib
ivt
rna
pcr
yield
band
signal
presenc
fulllength
genom
fig
lane
expect
fulllength
genom
amplifi
supernat
cell
infect
sinvwt
sinvg
moi
fig
lane
contrast
extra
lowmolecularweight
band
amplifi
sole
sampl
infect
sinvg
moi
fig
lane
verifi
put
defect
genom
encapsid
viral
particl
subject
viruscontain
supernat
rnase
treatment
follow
treatment
ivt
rna
solut
complet
degrad
amplifi
pcr
fig
lane
lowmolecularweight
band
detect
sinvg
highmoi
sampl
still
present
rnase
treatment
fig
lane
next
purifi
sequenc
band
yield
viral
genom
delet
span
mostli
code
sequenc
fig
expect
defect
genom
name
dg
retain
encapsid
signal
untransl
region
show
product
dg
northern
blot
sinvwt
g
submit
five
undilut
passag
concentr
ultracentrifug
sucros
cushion
rnase
treatment
extract
rna
pure
virion
popul
label
probe
overlap
dg
breakpoint
expect
ivt
rna
correspond
dg
sequenc
strongli
detect
fulllength
genom
ivt
rna
bare
detect
fig
lane
band
detect
uninfect
cell
fig
lane
sinvwt
sampl
fig
lane
sinvg
infect
show
clear
accumul
dg
fig
lane
addit
dg
appear
main
defect
genom
accumul
passag
abl
recov
truncat
genom
sequenc
use
similar
clone
techniqu
data
shown
use
qpcr
analyz
accumul
dg
highmoi
passag
first
primer
pair
locat
delet
region
dg
use
measur
amount
fulllength
genom
independ
primer
locat
end
dg
breakpoint
allow
specif
detect
dg
sinc
distanc
two
primer
fulllength
genom
great
permit
fulllength
genom
detect
fig
c
dg
quickli
accumul
highmoi
passag
sinvg
fig
reach
copi
per
fulllength
genom
passag
increas
ratio
dg
genom
invers
correl
viru
titer
throughout
passag
seri
fig
sinvwt
also
show
accumul
albeit
slower
dg
throughout
passag
indic
product
specif
dg
repres
uniqu
artifici
featur
sinvg
mutat
howev
moder
accumul
dg
sinvwt
could
explain
drop
titer
observ
passag
fig
thu
appli
ident
methodolog
isol
yet
anoth
defect
genom
sinvwt
passag
name
dwt
fig
despit
nucleotid
shorter
dwt
present
characterist
dg
intern
delet
note
primer
use
initi
detect
dg
qrtpcr
could
detect
dwt
due
larger
delet
expect
dwt
accumul
sinvwt
passag
reach
copi
per
fulllength
genom
fig
kinet
similarli
mirror
drop
sinvwt
titer
passag
dg
sinvg
show
stronger
accumul
dwt
earlier
passag
fig
taken
togeth
data
indic
sinvg
rapidli
produc
significantli
accumul
natur
occur
defect
genom
one
explan
earlier
drop
titer
sinvg
passag
could
product
greater
number
fulllength
genom
could
result
increas
accumul
genom
spike
deleteri
mutat
independ
gener
truncat
genom
hypothesi
support
fact
mutat
virus
lower
specif
infect
higher
elong
rate
howev
similar
accumul
fulllength
genom
detect
passag
virus
fig
rule
hypothesi
hand
accumul
dg
dwt
throughout
passag
could
explain
drop
titer
defect
genom
truli
interf
fulllength
genom
replic
expect
di
address
possibl
clone
dg
plasmid
dg
rna
synthet
vitro
cotransfect
cell
fix
amount
fulllength
rna
either
sinvwt
sinvg
increas
amount
dg
rna
assess
viral
titer
h
dg
rna
amount
increas
sinvwt
g
virus
viru
titer
drop
control
valu
dgfulllength
viru
ratio
show
dg
inde
interf
fulllength
viral
replic
fig
neg
control
use
fulllength
chikungunya
viru
rna
unabl
replic
instead
dg
rna
fig
addit
detect
dg
accumul
viral
supernat
transfect
cell
fig
recent
truncat
protein
express
di
influenza
viru
protein
implic
attenu
fulllength
viru
vitro
dg
dwt
conserv
intact
end
theoret
could
translat
yield
full
protein
well
chimer
protein
rule
particip
protein
product
attenu
fulllength
sinv
engin
dg
mutat
start
codon
orf
open
read
frame
cotransfect
fulllength
rna
inhibit
accumul
fulllength
viru
similar
fashion
fig
altern
approach
engin
stabl
bhk
cell
line
express
dg
first
kb
chikv
genom
qpcr
result
confirm
transcript
robustli
express
stabl
cell
line
data
shown
infect
h
sinvwt
fig
sinvg
fig
bhk
cell
express
either
dg
yield
time
less
viru
control
cell
line
cell
stabli
express
rna
di
product
reli
accid
replic
viral
replic
complex
jump
one
part
genom
anoth
distant
one
recombin
might
thu
driver
di
product
compar
recombin
kinet
sinvwt
sinvg
electropor
cell
two
segment
rna
could
gener
viabl
progeni
alon
one
code
four
protein
replic
complex
repliconwt
replicong
code
structur
protein
fig
measur
number
viabl
fulllength
genom
aros
recombin
interestingli
detect
fulllength
viru
soon
h
postelectropor
supernat
replicongelectropor
cell
fig
h
postelectropor
replicong
yield
time
infecti
viru
wildtyp
counterpart
verifi
plaqu
truli
correspond
fulllength
viru
naiv
cell
infect
viral
supernat
wt
g
electropor
h
extract
rna
cell
probe
viral
genom
northern
blot
fig
expect
fulllength
viru
detect
infect
overal
data
demonstr
rdrp
point
mutat
confer
mutat
statu
sinvg
also
confer
higher
recombin
rate
past
decad
isol
rdrp
mutat
sever
viral
famili
subsequ
attenu
vivo
led
conclus
fidel
critic
paramet
viru
fit
work
character
addit
featur
rna
viru
rdrp
mutat
abil
recombin
higher
rate
wildtyp
virus
recombin
rate
believ
depend
paramet
genom
organ
specif
viru
life
cycl
replic
exampl
high
process
rna
viru
rdrp
link
product
di
copi
choic
mechan
higher
process
replic
could
explain
characterist
sinv
mutat
increas
mutat
rate
less
time
discrimin
differ
nucleotid
format
di
probabl
jump
one
part
genom
anoth
hypothesi
support
recent
report
correl
mutat
phenotyp
elong
rate
mutant
picornavirus
correl
particularli
robust
mutant
palm
domain
structur
model
chikv
rdrp
local
residu
conserv
sinv
residu
palm
domain
work
monitor
evolut
sinvwt
sinvg
titer
throughout
passag
high
moi
cell
cultur
mutat
sinvg
display
earlier
drop
titer
wildtyp
counterpart
fig
explain
drop
could
invok
accumul
fulllength
genom
bear
deleteri
point
mutat
inde
cell
persist
infect
lymphocyt
choriomening
viru
lcmv
treat
mutagen
compound
target
viral
rdrp
viral
extinct
observ
accumul
deleteri
pointmut
viral
genom
howev
mutagen
treatment
lcmv
led
maximum
increas
mutat
rate
sinvg
possess
mutat
rate
wildtyp
viru
moreov
sinvwt
sinvg
display
similar
number
fulllength
genom
earli
passag
fig
thu
accumul
deleteri
fulllength
genom
unlik
reason
drop
titer
throughout
passag
hand
monitor
accumul
two
main
di
dg
dwt
highmoi
passag
sinvwt
sinvg
truncat
genom
dramat
accumul
reach
copi
dg
per
fulllength
genom
show
rna
speci
interfer
replic
fulllength
rna
rule
involv
protein
product
present
data
rule
possibl
involv
nonrepl
recombin
dg
dwt
format
fact
copi
choic
recombin
describ
main
mechan
di
format
well
increas
recombin
rate
sinvg
would
tend
incrimin
copi
choic
mechan
dg
dwt
format
moreov
sinvg
recombin
higher
rate
assum
replic
produc
divers
cloud
defect
genom
heterogen
size
breakpoint
site
small
portion
would
transmiss
cell
requir
signal
replic
end
genom
encapsid
protein
experi
dg
dwt
could
thu
consid
detect
tip
iceberg
vast
major
di
unabl
accumul
propag
high
number
could
still
impair
fulllength
viru
replic
note
defect
interfer
via
direct
inhibit
fulllength
viru
replic
could
effect
readili
detect
cell
lack
type
interferon
respons
overproduct
di
rna
viru
mutat
conserv
phenotyp
vivo
mutat
viabil
may
affect
direct
interfer
replic
activ
innat
immun
di
particl
previous
suggest
dg
dwt
sequenc
match
previous
publish
sinv
di
sequenc
believ
discrep
experiment
setup
account
differ
earli
studi
sinv
di
analyz
sampl
passag
numer
time
extrem
high
moi
setup
favor
accumul
nonphysiolog
di
isol
dg
dwt
h
infect
moi
furthermor
dg
dwt
fall
wellcharacter
categori
di
larg
intern
delet
reinforc
previou
observ
show
caa
gaa
sequenc
two
five
adenosin
residu
found
neighborhood
breakpoint
surpris
breakpoint
link
end
genom
dg
dwt
remark
conserv
di
format
primarili
occur
accid
transcript
replic
complex
jump
one
part
genom
anoth
hypothes
strong
rna
secondari
structur
present
area
provok
facilit
rdrp
jump
genom
old
world
alphavirus
bioinformat
predict
larg
unstructur
certain
region
sinv
genom
bear
strong
secondari
structur
involv
process
encapsid
howev
rna
secondari
structur
predict
use
mfold
softwar
program
yield
structur
interest
appli
genom
region
around
dg
dwt
breakpoint
data
shown
high
recombin
rate
rna
virus
might
benefici
viral
evolut
inde
thought
favor
accumul
advantag
mutat
genom
rescu
viru
two
deleteri
mutat
genom
howev
viral
recombin
might
also
consequ
genom
organ
anoth
paramet
select
pressur
regardless
data
show
increas
recombin
rate
coupl
consider
accumul
defect
genom
speci
sinv
defect
genom
abl
interfer
viral
replic
also
potent
type
interferon
induc
high
recombin
rate
could
detriment
viru
recombin
rate
might
thu
like
fidel
paramet
finetun
select
pressur
affect
viral
fit
deviat
evolutionarili
optim
valu
studi
mice
insect
would
provid
new
insight
relationship
recombin
defect
genom
product
vivo
attenu
fidel
variant
consid
interest
candid
live
attenu
vaccin
due
attenu
vivo
attenu
attribut
increas
mutat
rate
accumul
lethal
deleteri
mutat
hypothesi
strongli
support
experi
involv
lethal
mutagenesi
use
base
analog
howev
result
demonstr
higher
recombin
rate
larger
product
di
particl
also
characterist
mutat
viru
infect
rais
possibl
event
also
contribut
attenu
importantli
di
implic
preferenti
activ
type
interferon
bind
cytosol
rna
sensor
rigi
well
matur
dendrit
cell
high
immunogen
propos
potenti
vaccin
adjuv
consequ
rdrp
mutat
retain
higher
recombin
rate
di
overproduct
vivo
might
similar
effect
type
interferon
activ
futur
understand
role
paramet
increas
mutat
rate
increas
di
product
rdrp
mutat
phenotyp
would
help
defin
contribut
compon
vivo
attenu
remain
shown
whether
lower
rdrp
fidel
increas
recombin
ratesdi
product
alway
coupl
whether
rdrp
mutat
target
one
properti
either
case
use
mutat
variant
gener
excess
amount
di
could
new
way
engin
live
attenu
vaccin
strain
encod
adjuv
effect
